Caricamento...
Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
IMPORTANCE: Clinical trials of dupilumab for atopic dermatitis (AD) have reported an increased incidence of conjunctivitis in patients who received dupilumab compared with those who received placebo. OBJECTIVE: To describe the characteristics of patients who develop conjunctivitis secondary to dupil...
Salvato in:
| Pubblicato in: | JAMA Dermatol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Medical Association
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6233741/ https://ncbi.nlm.nih.gov/pubmed/30167653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.2690 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|